Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
leukemia
Biotech
Nurix trims staff as trial for lead BTK degrader kicks off
The company declined to disclose how many employees were affected by the workforce reduction but added that no programs have been cut or paused.
Darren Incorvaia
Nov 21, 2025 5:05am
MEI Pharma sheds biotech woes to rebrand as crypto company
Sep 10, 2025 9:58am
CEO props up Aptose's finances to keep biotech from going bust
Jun 17, 2025 10:04am
ADC Therapeutics calls time on sole clinical-stage candidate
May 14, 2025 9:55am
Kura, Kyowa hail ph. 2 win for leukemia drug, but hold back data
Feb 6, 2025 10:40am
Galecto buys leukemia drug, drops bone cancer asset in pivot
Oct 7, 2024 10:07am
